A carregar...

Minimal Residual Disease in Multiple Myeloma: Current Landscape and Future Applications With Immunotherapeutic Approaches

The basic principle that deeper therapeutic responses lead to better clinical outcomes in cancer has emerged technologies capable of detecting rare residual tumor cells. The need for ultra-sensitive approaches for minimal residual disease (MRD) detection is particularly evident in Multiple Myeloma (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Kostopoulos, Ioannis V., Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Tsitsilonis, Ourania E., Terpos, Evangelos
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7267070/
https://ncbi.nlm.nih.gov/pubmed/32537439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00860
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!